These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18316748)

  • 21. ACOG Committee Opinion no. 593: Management of women with dense breasts diagnosed by mammography.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2014 Apr; 123(4):910-1. PubMed ID: 24785636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation studies for models projecting the risk of invasive and total breast cancer incidence.
    Costantino JP; Gail MH; Pee D; Anderson S; Redmond CK; Benichou J; Wieand HS
    J Natl Cancer Inst; 1999 Sep; 91(18):1541-8. PubMed ID: 10491430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Breast Cancer.
    Croswell J; Owings J
    Am Fam Physician; 2016 Jul; 94(2):143-4. PubMed ID: 27419331
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast Cancer Screening: Why Can't Everyone Agree?
    Jordan V; Khan M; Prill D
    Prim Care; 2019 Mar; 46(1):97-115. PubMed ID: 30704663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors.
    Palomares MR; Machia JR; Lehman CD; Daling JR; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1324-30. PubMed ID: 16835331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone therapy and breast cancer risk: trumping fear with facts.
    Kaunitz AM
    Menopause; 2006; 13(2):160-3. PubMed ID: 16645526
    [No Abstract]   [Full Text] [Related]  

  • 27. Identifying women with dense breasts at high risk for interval cancer: a cohort study.
    Kerlikowske K; Zhu W; Tosteson AN; Sprague BL; Tice JA; Lehman CD; Miglioretti DL;
    Ann Intern Med; 2015 May; 162(10):673-81. PubMed ID: 25984843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen and breast density in women at increased risk of breast cancer.
    Cuzick J; Warwick J; Pinney E; Warren RM; Duffy SW
    J Natl Cancer Inst; 2004 Apr; 96(8):621-8. PubMed ID: 15100340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast density gains acceptance as breast cancer risk factor.
    Brower V
    J Natl Cancer Inst; 2010 Mar; 102(6):374-5. PubMed ID: 20215595
    [No Abstract]   [Full Text] [Related]  

  • 30. Breast cancer trends among young women in the United States.
    Tarone RE
    Epidemiology; 2006 Sep; 17(5):588-90. PubMed ID: 16804474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast-density legislation--practical considerations.
    Slanetz PJ; Freer PE; Birdwell RL
    N Engl J Med; 2015 Feb; 372(7):593-5. PubMed ID: 25671249
    [No Abstract]   [Full Text] [Related]  

  • 32. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis?
    Kremer ME; Downs-Holmes C; Novak RD; Lyons JA; Silverman P; Pham RM; Plecha DM
    AJR Am J Roentgenol; 2012 May; 198(5):1218-22. PubMed ID: 22528917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Efficacy of breast cancer screening in the community according to risk level.
    Duffy SW; Smith RA; Tabar L
    J Natl Cancer Inst; 2005 Nov; 97(22):1703; author reply 1703-4. PubMed ID: 16288125
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening for early breast cancer: pros and cons.
    Bailar JC
    Cancer; 1977 Jun; 39(6 Suppl):2783-95. PubMed ID: 872066
    [No Abstract]   [Full Text] [Related]  

  • 35. Summaries for patients. Screening mammography in women age 40 to 49 years.
    Ann Intern Med; 2007 Apr; 146(7):I20. PubMed ID: 17404347
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening Mammography in Women 40-49 Years Old: Current Evidence.
    Ray KM; Joe BN; Freimanis RI; Sickles EA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):264-270. PubMed ID: 29064760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Section Editor's Notebook: Breast Cancer Screening-What Now, and What Next?
    Javitt MC
    AJR Am J Roentgenol; 2018 Feb; 210(2):239-240. PubMed ID: 29355402
    [No Abstract]   [Full Text] [Related]  

  • 39. Mammographic density and estimation of breast cancer risk in intermediate risk population.
    Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
    Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammography in younger women: the dilemma of diminishing returns.
    Calonge N
    J Natl Cancer Inst; 2010 May; 102(10):668-9. PubMed ID: 20439837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.